Skip to content
Skip to footer
Home
Solution
Team
News
Contact
Close
Home
Solution
Team
News
Contact
News
Sartar was granted a Japan patent
January 25, 2019
Sartar was awarded a patent in Japan for the use of anagrelide in cancer therapy.
You May Also Like
News
Business Finland granted Sartar R&D Funding
News
Sartar’s therapy method featured in Drug Target Review
News
Sartar Therapeutics investment round was a success